
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 5.960 | 5.960 | 0.000 |
Shares | 94.040 | 94.040 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 31.077 | 16.083 |
Price to Book | 8.878 | 2.664 |
Price to Sales | 9.017 | 2.067 |
Price to Cash Flow | 24.341 | 10.256 |
Dividend Yield | 0.403 | 2.771 |
5 Years Earnings Growth | 16.281 | 12.234 |
Name | Net % | Category Average |
---|---|---|
Technology | 39.950 | 19.814 |
Financial Services | 19.630 | 20.278 |
Healthcare | 14.000 | 12.762 |
Communication Services | 9.730 | 9.277 |
Consumer Cyclical | 9.100 | 12.413 |
Industrials | 7.580 | 13.963 |
Number of long holdings: 23
Number of short holdings: 6
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
NVIDIA | US67066G1040 | 7.17 | 133.04 | -1.86% | |
Netflix | US64110L1061 | 7.09 | 1,180.64 | -0.92% | |
ASML ADR | USN070592100 | 6.81 | 743.15 | -0.80% | |
Visa A | US92826C8394 | 5.74 | 366.35 | -0.42% | |
Intuit | US4612021034 | 4.91 | 665.98 | -0.73% | |
Synopsys | US8716071076 | 4.78 | 509.27 | -1.31% | |
Airbnb | US0090661010 | 4.74 | 132.21 | -3.21% | |
S&P Global | US78409V1044 | 4.56 | 521.77 | -0.48% | |
Eli Lilly | US5324571083 | 4.44 | 753.00 | -0.28% | |
Intuitive Surgical | US46120E6023 | 4.39 | 555.67 | -1.06% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Adamant Medtech I EUR | 1.48B | -6.21 | 2.77 | 9.59 | ||
Adamant Medtech T EUR | 1.48B | -6.30 | 2.46 | 9.25 | ||
Bellevues Lux BB Adamant Medtech HB | 1.48B | 0.38 | 1.83 | 7.02 | ||
Adamant Medtech B EUR | 1.48B | -6.43 | 2.05 | 8.81 | ||
LU1477743386 | 313.81M | -5.34 | -3.16 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review